Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Research Frontiers (REFR) EBT Margin (2016 - 2025)

Historic EBT Margin for Research Frontiers (REFR) over the last 10 years, with Q3 2025 value amounting to 84.56%.

  • Research Frontiers' EBT Margin fell 191800.0% to 84.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 161.57%, marking a year-over-year decrease of 715500.0%. This contributed to the annual value of 107.96% for FY2024, which is 1155800.0% up from last year.
  • According to the latest figures from Q3 2025, Research Frontiers' EBT Margin is 84.56%, which was down 191800.0% from 627.47% recorded in Q2 2025.
  • Research Frontiers' 5-year EBT Margin high stood at 2.99% for Q3 2021, and its period low was 869.08% during Q2 2022.
  • In the last 5 years, Research Frontiers' EBT Margin had a median value of 283.87% in 2023 and averaged 291.51%.
  • As far as peak fluctuations go, Research Frontiers' EBT Margin surged by 5852200bps in 2023, and later tumbled by -6037500bps in 2025.
  • Quarter analysis of 5 years shows Research Frontiers' EBT Margin stood at 362.08% in 2021, then plummeted by -74bps to 631.31% in 2022, then soared by 74bps to 161.86% in 2023, then tumbled by -116bps to 350.42% in 2024, then surged by 76bps to 84.56% in 2025.
  • Its EBT Margin was 84.56% in Q3 2025, compared to 627.47% in Q2 2025 and 42.8% in Q1 2025.